In summary, TAMs may play an important role in promoting tumor growth, invasion and metastasis in TME of DLBCL, and CD163, as considered to be a marker relatively specific to M2 TAMs may serve as a better predictor than the pan-macrophage marker, CD68. Here, CD163 is linked to diffuse large B-cell lymphoma.